Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(85)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(106)
- Bcl-xL(8)
- c-RET(9)
- IAP(26)
- KEAP1-Nrf2(64)
- MDM2(12)
- p53(112)
- PC-PLC(4)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(6)
- Thymidylate Synthase(10)
- TNF-α(128)
- Other Apoptosis(885)
- APC(5)
- PD-1/PD-L1 interaction(60)
- ASK1(3)
- PAR4(2)
- RIP kinase(50)
- FKBP(19)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
- GC42743 AEM1 An inhibitor of Nrf2-induced gene expression
-
GC42735
Adipostatin A
5-十五烷基-1,3-苯二酚,Adipostatin A
A GPDH inhibitor -
GC42721
Ac-YVAD-CMK
Caspase-1 Inhibitor II
Ac-YVAD-CMK 是一种选择性不可逆的 caspase-1 抑制剂 (Ki=0.8nM),可阻止促炎细胞因子 IL-1β 的激活。 -
GC42719
Ac-WEAD-pNA (trifluoroacetate salt)
Ac-Trp-Glu-Ala-Asp-pNA, Ac-Trp-Glu-Ala-Asp-p-nitroanilide, Caspase-1 and Caspase-4 Chromogenic Substrate
A colorimetric caspase-1 and caspase-4 substrate -
GC42718
Ac-VEID-CHO (trifluoroacetate salt)
Ac-Val-Glu-Ile-Asp-CHO
A caspase-6 inhibitor -
GC42716
Ac-VDVAD-pNA (trifluoroacetate salt)
Ac-Val-Asp-Val-Ala-Asp-pNA, Caspase-2 Chromogenic Substrate, acetyl-Val-Asp-Val-Ala-Asp-p-nitroanilide, acetyl-VDVAD-p-nitroanilide
A colorimetric caspase-2 substrate -
GC42709
Ac-LEVD-CHO (trifluoroacetate salt)
Ac-Leu-Glu-Val-Asp-CHO, Caspase-4 Inhibitor I
A caspase-4 inhibitor -
GC42708
Ac-LEHD-AFC (trifluoroacetate salt)
N-Acetyl-Leu-Glu-His-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase-9 substrate (Fluorogenic)
A caspase-4, -5, and -9 fluorogenic substrate -
GC42689
Ac-DNLD-AMC
Ac-Asp-Asn-Leu-Asp-MCA, N-Acetyl-Asp-Asn-Leu-Asp-7-amido-Methylcoumarin, Caspase-3 Substrate
A fluorogenic caspase-3 substrate -
GC42688
Ac-DMQD-CHO (trifluoroacetate salt)
Ac-Asp-Met-Gln-Asp-CHO, Caspase-3 Inhibitor
An inhibitor of caspase-3 -
GC42687
Ac-DMQD-AMC (trifluoroacetate salt)
Ac-Asp-Met-Gln-Asp-AMC, Ac-Asp-Met-Gln-Asp-7-amino-4-methylcoumarin
A fluorogenic substrate for caspase-3 - GC42677 ABO (hydrochloride) A modulator of annexin A7
-
GC42659
A23187 (calcium magnesium salt)
Calcimycin
A cation ionophore -
GC42622
8-bromo-Cyclic AMP
8-溴腺苷-3',5'-环单磷酸
A PKA activator -
GC42616
7-oxo Staurosporine
BMY 41950, RK-1409
An antibiotic with diverse biological activities -
GC42586
6α-hydroxy Paclitaxel
6-羟基泰素
A metabolite of paclitaxel -
GC42545
5-Fluorouracil-13C,15N2
5-FU-13C,15N2
An internal standard for the quantification of 5-fluorouracil -
GC42401
4-hydroperoxy Cyclophosphamide
培磷酰胺,4-OOH-CY
4-hydroperoxy Cyclophosphamide(4-羟基过氧化环磷酰胺),环磷酰胺的活性代谢产物,能够交联DNA并独立于caspase受体激活诱导T细胞凋亡,通过产生活性氧(ROS)激活线粒体死亡途径。 -
GC42346
4-bromo A23187
4-溴代-钙离子载体,4-Bromocalcimycin
A non-fluorescent calcium ionophore - GC42237 3,5-dimethyl PIT-1 An inhibitor of PIP3/protein binding
-
GC42018
1-O-Octadecyl-2-O-methyl-sn-glycerol
2Methyl1octadecylsnglycerol, PIA 7
A PIA metabolite -
GC41983
19,20-Epoxycytochalasin D
19,20-环氧细胞松弛素D
A fungal metabolite -
GC41938
15-Lipoxygenase Inhibitor 1
15LO Inhibitor 1
An inhibitor of 15-LO -
GC41865
10'-Desmethoxystreptonigrin
10-去甲氧基链黑霉素
An antibiotic -
GC41742
(Z-IETD)2-Rh 110 (trifluoroacetate salt)
(Z-Ile-Glu-Thr-Asp)2-R110, Rhodamine 110 bis-(N-CBZ-IETD)2
A fluorogenic substrate for caspase-8 -
GC41739
(S)-nitro-Blebbistatin
S(-)7Desmethyl8nitro Blebbistatin
A more stable form of (–)-blebbistatin -
GC41719
(R)-nitro-Blebbistatin
R(-)7Desmethyl8nitro Blebbistatin
A more stable form of (+)-blebbistatin -
GC41716
(R)-CR8
(2R)-2-[[9-异丙基-6-[[[4-(2-吡啶基)苯基]甲基]氨基]-9H-嘌呤-2-基]氨基]-1-丁醇,CR8, (R)-Isomer
An inhibitor of cyclin-dependent kinases - GC41701 (E)-2-Hexadecenal Alkyne A click chemistry probe for a sphingolipid degradation product
-
GC41700
(E)-2-(2-Chlorostyryl)-3,5,6-trimethylpyrazine
CSTMP
A stilbene derivative with antioxidant and anticancer activities -
GC41698
(D)2-Rh 110 (trifluoroacetate salt)
D2R, (Asp)2-Rhodamine 110, Rhodamine 110 bis-(L-aspartic acid amide)
A fluorogenic caspase substrate -
GC41645
Jacaric Acid
8(Z),10(E),12(Z)-Octadecatrienoic Acid
A conjugated PUFA -
GC41643
9(Z),11(E),13(E)-Octadecatrienoic Acid
αEleostearic Acid, αESA, LAF 237
A polyunsaturated fatty acid -
GC41642
9(E),11(E),13(E)-Octadecatrienoic Acid
β-Eleostearic Acid, β-ESA
A polyunsaturated fatty acid - GC41640 Asterriquinol D dimethyl ether A fungal metabolite
-
GC41623
β-Elemonic Acid
β-岚香酮酸
A triterpene with anticancer activity -
GC41612
2'-O-Methylguanosine
2'-甲氧基鸟苷
A modified nucleoside -
GC41595
Matairesinol
罗汉松脂素
A lignan with diverse biological activities -
GC41584
Penicolinate A
Penicolinate B dimethyl ester
A fungal metabolite with diverse biological activities - GC41564 MPT0B014 An inhibitor of tubulin polymerization
-
GC41557
(S)-3'-amino Blebbistatin
(-)-3'-amino Blebbistatin, m-amino Blebbistatin, meta-amino Blebbistatin
A more stable form of (–)-blebbistatin -
GC41533
Silybin
水飞蓟宾
Hepatoprotective flavonoid and 5-LO inhibitor -
GC41514
Citreoviridin
黄绿青霉素
A mycotoxin that inhibits the mitochondrial ATPase -
GC41499
α-Phellandrene
水芹烯
A monoterpene with diverse biological activities -
GC41484
(S)-3'-hydroxy Blebbistatin
(-)-3'-hydroxy Blebbistatin, meta-hydroxy-Blebbistatin, m-hydroxy-Blebbistatin
A more stable form of (–)-blebbistatin -
GC41466
Reveromycin A
雷弗霉素A
A spiroketal antibiotic with antiproliferative activity -
GC41452
Luteoloside
木犀草苷; Luteolin 7-glucoside; Luteolin 7-O-β-D-glucoside
A flavanoid with diverse biological activities -
GC41409
Valilactone
缬基内酯,(-)-Valilactone
An esterase inhibitor - GC41384 K-TMZ A DNA alkylating agent
-
GC41345
(-)-α-Bisabolol
没药醇; (-)-α-Bisabolol
A sesquiterpene alcohol with diverse biological activities